Assistant Minister Ling Ji, also Deputy Representative in International Trade Negotiations, met with Lin Yiming, Executive Vice President of Danish Nuo and Nordic Company.

According to the Ministry of Commerce, on March 20, Vice Minister of Commerce and Deputy Representative for International Trade Negotiations Ling Ji met with Lin Yiming, Executive Vice President of Denmark's Novo Nordisk, to exchange views on topics such as the company's operations in China and development opportunities in China. Ling Ji stated that in recent years, China's technological innovation capabilities have rapidly improved, and the scale of the pharmaceutical and health industry has continued to expand. China, through new productive forces, is driving high-quality economic development and has become a global source of innovation. He hoped that Novo Nordisk would continue to deepen its presence in the Chinese market and contribute to the construction of a Healthy China. Lin Yiming expressed that Novo Nordisk is optimistic about the huge market potential in China and highly appreciates the Chinese government's continued efforts to optimize the business environment, strengthen intellectual property protection, and is willing to increase investment in China, expand localization of production and research and development, and help promote the vibrant growth of the pharmaceutical and health industry in China.